Navigation Links
DIA 45th Annual Meeting Features Sessions Highlighting Wyeth v. Levine and Pandemic Influenza

Two timely sessions at the DIA 45th Annual Meeting reflect the state of today's global biopharmaceutical environment.

Horsham, PA, USA (Vocus) June 5, 2009 -- The Drug Information Association (DIA) 45th Annual Meeting is the biopharmaceutical industry's largest and longest running global, multidisciplinary conference featuring sessions and preconference tutorials on issues affecting drug discovery and development, including two timely sessions reflecting the state of today's global biopharmaceutical environment.

The public policy/law track features a special session on Labeling Risk: Practical Approaches after Wyeth v. Levine (June 22; 1:30 - 3:00 pm).

In March 2009, The Wall Street Journal reported that the Supreme Court ruling in Wyeth v. Levine stated that pharmaceutical companies are not necessarily shielded from failure to warn product liability lawsuits in state courts when the US FDA has determined that approved labeling appropriately explains risk information, This session will explore practical approaches pharmaceutical companies should consider when disseminating risk information to minimize failure to warn liability and to maximize the possibility such liability is preempted.

"We will delve deep into the legal benefits of preemptions, describe regulatory and documentation strategies that maximize the availability of preemption in failure-to-warn lawsuits, and identify effective risk communication strategies," says Session Chair Patrick C O'Brien, JD, PharmD, Partner, Burke O'Neil LLC, United States.

Speakers include:

  • John B Moriarty, JD, Senior Vice President, Elan Pharmaceuticals, United States
  • Sandra A. Milligan, JD, MD, Executive Director, Amgen Inc., United States
Mary K. Pendergast, JD, LLM, President, Pendergast Consulting, United States
This year's biotechnology track includes a timely session on Regulatory Methods to Facilitate the Approval of Biological Products to Address Pandemic Influenza (June 22, 1:30 - 3:00 pm).

This session incorporates descriptions of novel regulatory mechanisms for vaccine approval with a discussion of successful applications for pandemic influenza.

"This must-attend session will attempt to identify novel regulatory approaches to vaccine approval, industry approaches toward interactions with the FDA, and novel biochemical methods for the development of vaccines," explains Session Chair Richard M Lewis, PhD, CEO, Access BIO, United States.

Speakers include:

  • Jean L Hu-Primmer, MS, Program Manager, Pandemic and Emerging Threat Preparedness, OD, CBER, USFDA
  • John Purves, PhD, Head of Sector, Quality of Medicines, European Medicines Agency
  • Ozzie Berger, Senior Director and Head, Influenza Vaccines, US Regulatory Affairs, Biologicals, GlaxoSmithKline

About the Drug Information Association (DIA)
DIA serves more than 30,000 professionals involved in the biopharmaceutical industry and regulatory affairs worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China, the Association is led by its volunteer-based Board of Directors and executive management team.

Joe Krasowski

Bonnie Shaw
Clearpoint Agency, Inc.

# # #

Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Council of State and Territorial Epidemiologists Annual Conference Begins June 7 in Buffalo, NY
2. NeoGenomics to Present at Noble Financials 5th Annual Equity Conference on Monday, June 8th
3. Isis Pharmaceuticals to Present at Needhams 8th Annual Life Sciences Conference
4. NuVasive to Present at the 8th Annual Needham Life Sciences Conference
5. Maggianos Little Italy(R) Celebrates Sixth Annual Eat-A-Dish for Make-A-Wish(R) in Chicago
6. Trubion to Present at the 8th Annual Needham Life Sciences Conference
7. Photos: Tommy & Thalia Mottola Honored at 7th Annual FedEx/St. Jude Angels & Stars Gala
8. Accuray Incorporated to Present at Eighth Annual Needham Life Sciences Conference
9. Medivation to Present at 8th Annual Needham Life Sciences Conference
10. Isis Pharmaceuticals to Present at Goldman Sachs 30th Annual Global Healthcare Conference
11. Cepheid Announces Symposium Program for 2009 Association for Professionals in Infection Control (APIC) Annual Conference
Post Your Comments:
Related Image:
DIA 45th Annual Meeting Features Sessions Highlighting Wyeth v. Levine and Pandemic Influenza 
(Date:11/30/2015)... BALTIMORE, Md. (PRWEB) , ... November 30, 2015 ... ... be rewarding, but also extremely stressful. At the VA Maryland Health Care ... who care for veterans patients. “Caregivers have a difficult job. Seventy-four percent ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... (Meso Foundation) released information for caregivers and held two webinars on topics of ... on demand free of charge at . , With a loved ...
(Date:11/30/2015)... ... 30, 2015 , ... According to research by the National ... technicians to be certified or obtain continuing education. To increase awareness of the ... Mouth?” campaign to inform dentists that the technicians they trust could lack the ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... . The directory is specialized and only includes chiropractic clinics in the ... a competent and trustworthy alternative health practitioner when back pain sets in. When ...
(Date:11/30/2015)... ... 30, 2015 , ... The Museum of Science & Industry ... new era of publicly accessible automated technology. Now, by popular demand, the Meridian ... an up-close look at the shuttle at MOSI’s main entrance. This experience continues ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... Free Press as a Top Workplace , among the ... work for in 2015. ... annually, based on employee surveys rating company leadership, career opportunities, ... based solely on employee feedback. The survey is conducted by ...
(Date:11/30/2015)... Va. , Nov. 30, 2015  IBA Molecular ... manufacture and distribution of radiopharmaceuticals, announced that as of ... Pharma, Inc. (Zevacor Pharma). The decision to rebrand the ... the firm as well as its close relationship with ... by Illinois Health and Science (IHS). ...
(Date:11/30/2015)... , Nov. 30, 2015 Baxalta ... biopharmaceutical leader dedicated to delivering transformative therapies ... medical conditions, today announced the launch and ... PEGylated], an extended circulating half-life recombinant factor ... on full-length ADVATE [Antihemophilic Factor (Recombinant)]. The ...
Breaking Medicine Technology: